Arkolith/Insider Trading/RLAY/Form 4

Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Apr 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$182K
Net Open-Market Flow
-$182K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2025Sell(S)19K$2.97$55K822K
Apr 23, 2025Sell(S)43K$2.97$127K840K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-057996) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML